Trevi Therapeutics, Inc. (TRVI) Insider Ownership

Historic Insider Ownership Trends

As of June 18, 2026, the three largest insider holders of TRVI are Ali Behbahani (TenPercentOwner, 11.37Mn shares), Mohamad Makhzoumi (TenPercentOwner, 11.37Mn shares), Carmen Chang (TenPercentOwner, 11.37Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Jennifer L Good President Ceo 213,313 0 25 Mar, 2025
Thomas Sciascia Chief Scientific Officer 221,373 0 26 Mar, 2025
Scott D Sandell - 0 11,370,376 13 Apr, 2022
Forest Baskett - 0 10,421,428 13 Apr, 2022
Edward T Mathers - 0 948,948 13 Apr, 2022
David P Meeker - 352,489 0 29 Aug, 2024
Christopher Galletta - 26,095 0 03 Dec, 2025
Paul Edward Walker - 0 11,370,376 13 Apr, 2022
Peter W. Sonsini - 0 11,370,376 13 Apr, 2022
Anthony A. Jr. Florence - 0 11,370,376 13 Apr, 2022
Ali Behbahani - 0 11,370,376 13 Apr, 2022
Mohamad Makhzoumi - 0 11,370,376 13 Apr, 2022
Enterprise Associates 16, L.P. New - 10,421,428 0 13 Apr, 2022
Carmen Chang - 0 11,370,376 13 Apr, 2022
Lisa Delfini Chief Financial Officer 64,660 0 10 Jan, 2025
Gp A, Llc Tpg - 0 3,824,883 06 Jul, 2022
Farrell Simon Chief Commercial Officer 76,900 0 12 Mar, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
19 Feb, 2026 Farrell Simon Stock Option (right to buy) A 160,000 $0.00 160,000 D A
19 Feb, 2026 Thomas Sciascia Stock Option (right to buy) A 85,000 $0.00 85,000 D A
19 Feb, 2026 Jennifer L Good Stock Option (right to buy) A 675,000 $0.00 675,000 D A
19 Feb, 2026 Christopher Galletta Stock Option (right to buy) A 35,000 $0.00 35,000 D A
19 Feb, 2026 James V Cassella Stock Option (right to buy) A 215,000 $0.00 215,000 D A
08 Jan, 2026 David C Hastings Stock Option (right to buy) A 375,000 $0.00 375,000 D A
02 Dec, 2025 Christopher Galletta Common Stock A 4,225 $0.51 26,095 D M
02 Dec, 2025 Christopher Galletta Stock Option (right to buy) D 4,225 $0.00 15,775 D M
11 Jun, 2025 Michael Thomas Heffernan Nonstatutory Stock Option (right to buy) A 45,000 $0.00 45,000 D A
11 Jun, 2025 Dominick Colangelo Nonstatutory Stock Option (right to buy) A 45,000 $0.00 45,000 D A
11 Jun, 2025 Edward T Mathers Nonstatutory Stock Option (right to buy) A 45,000 $0.00 45,000 D A
11 Jun, 2025 Anne Vanlent Nonstatutory Stock Option (right to buy) A 45,000 $0.00 45,000 D A
11 Jun, 2025 David P Meeker Nonstatutory Stock Option (right to buy) A 45,000 $0.00 45,000 D A
31 May, 2025 Lisa Delfini Performance Stock Option (right to buy) A 72,000 $0.00 110,400 D A
31 May, 2025 Christopher Galletta Performance Stock Option (right to buy) A 8,550 $0.00 13,110 D A
31 May, 2025 Jennifer L Good Performance Stock Option (right to buy) A 102,000 $0.00 156,400 D A
31 May, 2025 Farrell Simon Performance Stock Option (right to buy) A 72,000 $0.00 110,400 D A
31 May, 2025 Thomas Sciascia Performance Stock Option (right to buy) A 60,000 $0.00 92,000 D A
25 Mar, 2025 Thomas Sciascia Common Stock A 2,631 $1.43 224,004 D M
25 Mar, 2025 Thomas Sciascia Common Stock D 2,631 $6.60 221,373 D S